Filter
496
Filtered Results: 496
Text search:
The
South
African
Cochraine
Centre
Featured
Recommendations
64
New Publications
99
Language
Document type
No document type
271
Guidelines
97
Studies & Reports
92
Manuals
20
Training Material
7
Fact sheets
4
Situation Updates
2
Strategic & Response Plan
2
Resource Platforms
1
Countries / Regions
Global
25
South Africa
18
Western and Central Europe
9
Eastern Europe
9
Nigeria
7
Africa
7
India
7
Mozambique
6
Ethiopia
6
Liberia
6
Sierra Leone
5
Latin America and the Carribbean
5
Russia
5
Kenya
4
Ukraine
4
Nepal
3
Lesotho
3
Malawi
3
Asia
3
South–East Asia Region
3
Angola
3
Thailand
2
Rwanda
2
Cameroon
2
Zimbabwe
2
Guinea
2
Guinea-Bissau
2
Tanzania
2
West and Central Africa
2
East and Southern Africa
2
Uganda
2
Brazil
2
Namibia
2
Botswana
2
Zambia
2
Colombia
1
Ghana
1
Benin
1
Syria
1
Burkina Faso
1
Afghanistan
1
Qatar
1
USA
1
Haiti
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
North America
1
France
1
Southern Africa
1
Argentina
1
Bangladesh
1
Vietnam
1
Yemen
1
South Sudan
1
Indonesia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
101
Countries
86
Women & Child Health
64
Public Health
34
Key Resources
12
Pharmacy & Technologies
8
Capacity Building
3
Toolboxes
Mental Health
72
TB
56
HIV
51
COVID-19
38
Caregiver
26
NCDs
24
AMR
15
NTDs
13
Disability
11
Planetary Health
10
Rapid Response
7
Refugee
7
Ebola & Marburg
7
Pharmacy
5
Social Ethics
4
Global Health Education
4
Natural Hazards
3
Zika
3
Polio
3
Specific Hazards
2
Cholera
2
Health Financing Toolbox
1
Conflict
1
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Choko AT et al. Journal of the International AIDS Society 2017, 20:21610 http://www.jiasociety.org/index.php/jias/article/view/21610 | http://dx.doi.org/10.7448/IAS.20.1.21610
To provide a foundation for the strategic policy and programme development needed to ensure the sustainable implementation of effective interventions for reducing the global burden of PPH
Report of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z
BMC Health Services Research (2017) 17:623 DOI 10.1186/s12913-017-2567-7
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
The purpose of this document is to address specific needs and considerations for essential oral health services in the context of COVID-19 in accordance with WHO operational guidance on maintaining essential health services. This interim guidance is intended for public health authorities, chief dent...
Access to medical personal protective equipment (PPE) is essential for routine healthcare delivery, and a critical tool for containing outbreaks, as well as preventing and responding to pandemics. It is one of our most effective tools against COVID-19, and an undervalued tool more generally in infec...
